<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-08-26T13:36:10Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/60BB5DEB-4BE7-46FB-9811-2D957F2B1756" ns1:id="60BB5DEB-4BE7-46FB-9811-2D957F2B1756"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/8C8E5F74-FD5A-4EAE-AA59-9DEA8B3A401B" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/8C8E5F74-FD5A-4EAE-AA59-9DEA8B3A401B" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2015-01-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/76DE8D8A-8D58-4136-B137-1A311EB883F3" ns1:rel="FUND" ns1:start="2014-07-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">751495</ns2:identifier></ns2:identifiers><ns2:title>Nematode cyst extractor</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Vouchers</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Soil Essentials is a leading precision-farming SME based in Scotland becoming increasingly engaged in innovative R&amp;amp;D to boost agricultural productivity. A major challenge exists with detection and control of cyst nematodes (CN), which are currently associated with UK economic losses of &amp;pound;38 M pa. With the additional pressure of the foreseeable nematicide ban, the opportunity for new in-field diagnostics for more efficient on-farm decision making is timely. However, successful translation of existing CN assays from lab to field is being hindered by the challenging multi-step sample processing requirements necessary to isolate CN from soil samples prior to analysis. This innovation voucher will give us access to a cutting-edge sample processing technology platform, which has the potential to bridge the gap between lab-based CN diagnostics and in-field commercial requirements. If successful, it will open up possibilities for future UK-based collaborative R&amp;amp;D investment.</ns2:abstractText></ns2:project>